Chronic Prostatitis/Chronic Pelvic Pain Syndrome Patients

August 28, 2023 updated by: Basri Cakiroglu, Hisar Intercontinental Hospital

Retrospective Data Analysis in Chronic Prostatitis/Chronic Pelvic Pain Syndrome Patients: Evaluation of the Relationship Between Presence of Microorganism and Severity of Symptom

Chronic prostatitis/chronic pelvic pain syndrome (CPPS) is a common health problem among men and can cause severe quality of life. The pathophysiology of CPPS is still poorly understood and effective treatments are a challenging issue. This study aims to investigate the possible relationship between the presence of microorganisms in the prostatic fluid and symptom severity by presenting a retrospective analysis based on data from CPPS patients.

Study Overview

Status

Completed

Conditions

Intervention / Treatment

Detailed Description

This study is based on data from 112 CPPS patients aged 20-60 years. Various variables such as demographic information of the patients, International Prostate Symptom Score (I-PSS), which evaluates CPPS symptoms, inflammatory and non-inflammatory symptoms of CPPS, baseline scores of the International Index of Erectile Function (IIEF), which evaluates erectile function, and the presence of microorganisms in the prostate fluid were analyzed retrospectively.

Study Type

Observational

Enrollment (Actual)

112

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

  • Turkey
      • Istanbul, Turkey, 34768
        • Hisar Intercontinental Hospital

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

  • Adult

Accepts Healthy Volunteers

Yes

Sampling Method

Probability Sample

Study Population

This study is based on data from 112 CPPS patients aged 20-60 years. Various variables such as demographic information of the patients, International Prostate Symptom Score (I-PSS), which evaluates CPPS symptoms, inflammatory and non-inflammatory symptoms of CPPS, baseline scores of the International Index of Erectile Function (IIEF), which evaluates erectile function, and the presence of microorganisms in the prostate fluid were analyzed retrospectively.

Description

Inclusion Criteria:

  • Patients who were diagnosed with chronic prostatitis/chronic pelvic pain syndrome and whose prostate fluid was taken with prostate massage and androflor testis were studied were included.

Exclusion Criteria:

  • acute and/or chronic bacterial prostatitis, active history of genitourinary cancer, history of recent prostate surgery the diagnosis of neurological diseases affecting the bladder was determined

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

Cohorts and Interventions

Group / Cohort
Intervention / Treatment
singel
Diagnostic test: Chronic prostatitis/chronic pelvic pain syndrome
Chronic prostatitis/chronic pelvic pain syndrome UPOINT

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Correlation between androflor pcr positive patients and uopint and nih-cpsi
Time Frame: 2 years
Those with positive and negative Androflor PCR test will be evaluated. testicular torsion
2 years

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Sponsor

Hisar Intercontinental Hospital

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

January 1, 2020

Primary Completion (Actual)

December 31, 2022

Study Completion (Actual)

May 10, 2023

Study Registration Dates

First Submitted

August 16, 2023

First Submitted That Met QC Criteria

August 28, 2023

First Posted (Actual)

August 29, 2023

Study Record Updates

Last Update Posted (Actual)

August 29, 2023

Last Update Submitted That Met QC Criteria

August 28, 2023

Last Verified

August 1, 2023

More Information

Terms related to this study

Additional Relevant MeSH Terms

Other Study ID Numbers

  • 16.08.2023/23-43

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Chronic Prostatitis With Chronic Pelvic Pain Syndrome

Clinical Trials on Chronic prostatitis/chronic pelvic pain syndrome

Search Similar Trials

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Iran

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations

Subscribe